Balyasny Asset Management’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.98M Buy
386,290
+329,616
+582% +$8.52M 0.02% 692
2025
Q1
$578K Buy
+56,674
New +$578K ﹤0.01% 1533
2024
Q4
Sell
-20,023
Closed -$390K 2229
2024
Q3
$390K Buy
20,023
+2,419
+14% +$47.2K ﹤0.01% 1635
2024
Q2
$327K Sell
17,604
-2,372
-12% -$44.1K ﹤0.01% 1587
2024
Q1
$280K Sell
19,976
-53,357
-73% -$748K ﹤0.01% 1678
2023
Q4
$622K Sell
73,333
-15,578
-18% -$132K ﹤0.01% 1347
2023
Q3
$794K Buy
88,911
+85,946
+2,899% +$768K ﹤0.01% 1196
2023
Q2
$25.6K Buy
+2,965
New +$25.6K ﹤0.01% 1751
2022
Q4
Sell
-967
Closed -$46K 2596
2022
Q3
$46K Buy
+967
New +$46K ﹤0.01% 2001
2022
Q2
Sell
-44,588
Closed -$3.61M 2567
2022
Q1
$3.61M Buy
44,588
+42,556
+2,094% +$3.44M 0.01% 848
2021
Q4
$412K Sell
2,032
-9,536
-82% -$1.93M ﹤0.01% 1437
2021
Q3
$3.12M Buy
+11,568
New +$3.12M 0.01% 808
2020
Q1
Sell
-8,952
Closed -$2.9M 1287
2019
Q4
$2.9M Buy
+8,952
New +$2.9M 0.02% 593
2019
Q3
Sell
-10,789
Closed -$5.76M 1291
2019
Q2
$5.76M Sell
10,789
-773
-7% -$413K 0.04% 479
2019
Q1
$5.83M Buy
11,562
+4,909
+74% +$2.47M 0.04% 475
2018
Q4
$3.28M Buy
6,653
+5,753
+639% +$2.84M 0.02% 519
2018
Q3
$823K Buy
+900
New +$823K ﹤0.01% 1019
2018
Q2
Hold
0
1812
2018
Q1
Sell
-1,933
Closed -$1.73M 1940
2017
Q4
$1.73M Sell
1,933
-50,919
-96% -$45.6M 0.01% 949
2017
Q3
$19M Buy
52,852
+18,784
+55% +$6.76M 0.07% 289
2017
Q2
$9.99M Buy
34,068
+4,880
+17% +$1.43M 0.04% 455
2017
Q1
$10.3M Buy
+29,188
New +$10.3M 0.05% 423
2016
Q1
Sell
-1,976
Closed -$500K 1230
2015
Q4
$500K Buy
+1,976
New +$500K ﹤0.01% 698
2015
Q3
Sell
-1,071
Closed -$201K 1116
2015
Q2
$201K Buy
+1,071
New +$201K ﹤0.01% 782